After @ doses of an H@N@ formulation containing @ g of hemagglutinin given without adjuvant , with AS@ adjuvant , or with MF@ adjuvant , the proportion achieving an HIA titer of @ or higher was @ % ( @ % CI , @ % -@ % ) without adjuvant ( n = @ ) , @ % ( @ % CI , @ % -@ % ) with AS@ adjuvant ( n = @ ) , and @ % ( @ % CI , @ % -@ % ) with MF@ adjuvant ( n = @ ) ( P < @ for comparison of the AS@ and MF@ schedules ) .